MODEL RELEASED. Xenical anti-obesity drug. Obese woman holds a bubble pack of Xenical (orlistat) anti-obesity capsules,for use in weight loss. Released in the USA in 1998,it is a non-systemic lipase inhibitor drug or fat blocker. Unlike many other diet drugs,this drug does not achieve its effect by acting on the brain. It acts on the gastro-intestinal tract to prevent the absorption of fat by about 30 percent. In a one-year clinical trial,the average patient weighing 220 pounds lost 20 pounds (10% body weight) taking Xenical on a moderately reduced calorie diet. Xenical also reduces LDL cholesterol in the blood. Obese people weigh 20% or more of their desirable body weight | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / SATURN STILLS |
Taille de l’image : | 3519 px × 3552 px |
Model Release : | Disponible |
Property Release : | Non requis |
Restrictions : | - |